Detalles de la búsqueda
1.
High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection.
Parasitology
; 146(3): 322-332, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30198459
2.
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals.
Cell Immunol
; 334: 61-69, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287082
3.
Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.
Cell Immunol
; 323: 59-69, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29128045
4.
Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis.
Int J Mol Sci
; 19(1)2018 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301342
5.
An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humans.
Cell Immunol
; 318: 42-48, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28602279
6.
Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis.
Microb Pathog
; 110: 14-22, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28629727
7.
Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.
Immunobiology
; 224(1): 163-171, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266201
8.
Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical protein.
Parasitol Int
; 67(3): 344-350, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29408435
9.
Identification of immune biomarkers related to disease progression and treatment efficacy in human visceral leishmaniasis.
Immunobiology
; 223(3): 303-309, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29074301
10.
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up.
Diagn Microbiol Infect Dis
; 92(3): 196-203, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29941364
11.
Leishmania infantum mimotopes and a phage-ELISA assay as tools for a sensitive and specific serodiagnosis of human visceral leishmaniasis.
Diagn Microbiol Infect Dis
; 87(3): 219-225, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27939286
12.
Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice.
Acta Trop
; 171: 8-16, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28288798
13.
Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis.
Mol Immunol
; 91: 272-281, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28988041
14.
New serological tools for improved diagnosis of human tegumentary leishmaniasis.
J Immunol Methods
; 434: 39-45, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27090730
Resultados
1 -
14
de 14
1
Próxima >
>>